Dr. Jane Grogan is chief scientific officer of Graphite Bio, a gene editing and cell therapy company, leading clinical research and development efforts. Prior to Graphite Bio, Dr. Grogan was chief scientific officer at ArsenalBio; and head of adaptive tumor immunity and principal scientist of cancer immunology at Genentech. Her work has identified key regulators and epigenetic modifiers of immune cells, including TIGIT, for autoimmune and oncology indications. Dr. Grogan has published over 60 papers in a wide array of journals and is the inventor on over 20 patents. She obtained her Ph.D. from Leiden University, her BSci (Hons) degree from the University of Melbourne, and her post-doctoral training as an Alexander von Humboldt Fellow at the German Rheumatism Research Centre Berlin and as a Howard Hughes Fellow at UCSF.
Jane Grogan, Graphite Bio